Braidwell’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9M Buy
677,570
+136,680
+25% +$9.57M 1.17% 33
2025
Q4
$49.9M Sell
540,890
-342,857
-39% -$32.8M 1.6% 23
2025
Q3
$65.6M Buy
883,747
+361,337
+69% +$36.6M 1.95% 15
2025
Q2
$67.8M Buy
522,410
+220,000
+73% +$31.9M 2.32% 17
2025
Q1
$48.2M Buy
302,410
+9,000
+3% +$1.63M 1.69% 24
2024
Q4
$54.4M Buy
293,410
+54,499
+23% +$10.6M 1.61% 25
2024
Q3
$50.4M Sell
238,911
-140,532
-37% -$24.4M 1.43% 30
2024
Q2
$50.8M Buy
379,443
+277,951
+274% +$52.6M 1.59% 27
2024
Q1
$21.8M Sell
101,492
-83,166
-45% -$16.3M 0.7% 45
2023
Q4
$37.6M Buy
184,658
+84,358
+84% +$13.7M 1.38% 29
2023
Q3
$19.9M Buy
+100,300
New +$25.3M 0.63% 51

Other funds holding INSP

Braidwell's INSP Position: Q1 2026 in Review

Braidwell increased its Inspire Medical Systems (INSP) stake by 25% in Q1 2026, buying an estimated $9.57M and bringing the position to 677,570 shares worth $34.9M. The position accounts for 1.17% of the portfolio, ranked #33.

Braidwell first reported a position in INSP in Q3 2023 and has held it in 11 quarters since. The position peaked at $67.8M in Q2 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Braidwell held 677,570 shares of Inspire Medical Systems worth $34.9M as of Q1 2026.
  • Braidwell bought 136,680 Inspire Medical Systems shares in Q1 2026, an estimated $9.57M.
  • Inspire Medical Systems made up 1.17% of Braidwell's portfolio in Q1 2026, its #33 holding.
  • Braidwell first reported a position in Inspire Medical Systems in Q3 2023 and has held it in 11 quarters since.
  • Braidwell's Inspire Medical Systems position peaked at $67.8M in Q2 2025.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Braidwell's 13F filing for Q1 2026, filed 15 May 2026.